25 November, 2016  – Lumeon, a leading digital health company, has been named to the “Global Digital Health 100” by The Journal of mHealth. The list recognises global companies delivering innovation in mobile, digital and connected healthcare.

The Global Digital Health 100 represents 6 months of analysis by the editorial and advisory team at The Journal of mHealth. The selected companies demonstrate true innovation and the opportunity to disrupt the delivery of healthcare at scale. The selection criteria ensure that companies are considered truly upon innovation, allowing start-up offerings to be compared alongside established and larger organisations. This year’s list also identifies an industry that is showing the signs of maturity. The 2016 cohort shows that it is essential to not only demonstrate innovation in technology, but also innovation in service and business model development as a requisite to succeeding as a technology company in the healthcare industry.

Lumeon is at the forefront of delivering innovative digital healthcare with Care Pathway Manager, which enables providers to unify clinical and administrative workflow automation delivering efficiency improvements of over 50% and keeps clinicians operating at the “top of their license”. Lumeon works with seven of the 10 leading independent healthcare providers in the UK, including Alliance Medical, Bupa and Nuffield Health, to create state-of-the-art care pathways that generate the best possible outcomes at the lowest cost.

Robbie Hughes, Lumeon CEO said, “There’s a growing need within the industry to deliver improved measurable patient outcomes whilst reducing operational costs, and it takes a change of thinking to achieve that vision. Lumeon was founded with that vision in mind, so we’re pleased to be recognised by The Journal of mHealth for delivering that innovation to the healthcare sector.”